-
2541
COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU
Published 2018-07-01“…In Kursk, the ratio of these specified tactics of combined therapy was 53.5 and 34.1%, respectively. Among the pharmaceutical companies whose medicines were preferred by doctors in Kursk and in Chisinau, the leading positions were taken by KRKA (38.0 and 25.4%, respectively), Gideon Richter (13.5 and 28.7%, respectively) and Berlin-Chemie (26.7 and 15.6%, respectively).Conclusion. …”
Get full text
Article -
2542
Optimization of the production process for the anticancer lead compound illudin M: downstream processing
Published 2022-08-01“…However, limitations related to the discovery and supply of these molecules by biotechnological means led to the retraction of big pharmaceutical companies from this field. The reasons included problems associated with strain culturing, screening, re-discovery, purification and characterization of novel molecules from natural sources. …”
Get full text
Article -
2543
Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study
Published 2020-12-01“…Background: Health technology assessment (HTA) has increased in importance in supporting payer decision making by assessing the relative effectiveness and cost effectiveness of new medicines. Thus, pharmaceutical companies need to address the HTA requirements early during development to improve reimbursement outcomes. …”
Get full text
Article -
2544
Phenotypic variation in biomass and related traits among four generations advanced lines of Cleome (Gynandropsis gynandra L. (Briq.)).
Published 2022-01-01“…Gynandropsis gynandra (spider plant) is an African traditional leafy vegetable rich in minerals, vitamins and health-promoting compounds with potential for health promotion, micronutrients supplementation and income generation for stakeholders, including pharmaceutical companies. However, information on biomass productivity is limited and consequently constrains breeders' ability to select high-yielding genotypes and end-users to make decisions on suitable cultivation and production systems. …”
Get full text
Article -
2545
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access ProtocolResearch in context
Published 2024-04-01“…Funding: The DRUG Access Protocol is supported by all participating pharmaceutical companies: Bayer, Janssen, Lilly, Merck, Novartis, Roche, and Sanofi.…”
Get full text
Article -
2546
Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
Published 2008“…Reference lists of relevant papers and previous systematic reviews were hand-searched. Pharmaceutical companies and experts in this field were contacted for supplemental data. …”
Journal article -
2547
Evaluation of an in silico cardiac safety assay: Using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge
Published 2013“…Introduction: Drugs that prolong the QT interval on the electrocardiogram present a major safety concern for pharmaceutical companies and regulatory agencies. Despite a range of assays performed to assess compound effects on the QT interval, QT prolongation remains a major cause of attrition during compound development. …”
Journal article -
2548
Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data
Published 2019“…<br/><strong>Methods: </strong>We identified all placebo-controlled, double-blind randomised controlled trials (RCTs) of second generation antidepressants for major depressive disorder conducted in Japan and requested their individual patient data (IPD) to pharmaceutical companies. We obtained IPD (n=1493) from four phase II/III RCTs comparing mirtazapine, escitalopram, duloxetine, paroxetine and placebo. …”
Journal article -
2549
Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: A consensus statement from the European Society for Clinical and Econom...
Published 2019“…CONCLUSIONS:These recommendations may contribute to improve transparency in the field of safety of anti-OA medications. Pharmaceutical companies developing drugs for OA, and researchers conducting clinical trials, are encouraged to comply with them when reporting harms-related results in manuscripts on RCTs. …”
Conference item -
2550
Identification of Bioactive Compounds from Marine Natural Products and Exploration of Structure-Activity Relationships (SAR)
Published 2021-03-01“…This method is a novel strategy to overcome insufficient quantities of pure material (NPs) for drug discovery and development which is a big challenge for pharmaceutical companies. The antibacterial screening of the marine extracts has shown several of the compounds exhibited potent in-vitro antibacterial activity, especially against methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) with minimum inhibitory concentration (MIC) values between 15.6 to 62.5 microg mL<sup>−1</sup>. …”
Get full text
Article -
2551
Attitudes towards the COVID-19 Vaccine and Willingness to Get Vaccinated among Healthcare Workers in French Guiana: The Influence of Geographical Origin
Published 2021-06-01“…Conversely, participants were less likely to have been vaccinated or willing to if they were nurses or of another non-medical profession, born in French Guiana, feared adverse effects, or if they did not trust pharmaceutical companies and management of the epidemic by authorities. …”
Get full text
Article -
2552
Neglected Tropical Diseases and the Millennium Development Goals-why the "other diseases" matter: reality versus rhetoric
Published 2011-12-01“…This has been made possible by donations from major pharmaceutical companies of quality and efficacious drugs which have a proven track record of safety. …”
Get full text
Article -
2553
Quality assurance in non-interventional studies
Published 2009-11-01“…In addition in Germany the Federal Institute for Drugs and Medical Devices (BfArM) together with the Paul Ehrlich Institute (PEI) and the German Association of Research-Based Pharmaceutical Companies (VFA) have published respectively recommendations dealing with quality aspects of non-interventional observational studies. …”
Get full text
Article -
2554
Hesitancy to COVID-19 Vaccines among University Students in Lebanon
Published 2022-03-01“…Students reporting that pharmaceutical companies adequately tested the safety of the vaccine (OR=0.52; 95% CI=0.19-1.43; p value=0.21) and those who consider the vaccine in agreement with their personal views (OR= 0.11, 95% CI= 0.02-0.51, p value= 0.004) were less likely to be hesitant. …”
Get full text
Article -
2555
Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization studyResearch in context
Published 2019-03-01“…Although many pharmaceutical companies are developing drugs targeting GFRAL, whether the findings from animal studies can be extrapolated to man is unknown. …”
Get full text
Article -
2556
Global trends in the health economics field of PD-1/PD-L1 inhibitors: A bibliometric and visualized study
Published 2023-03-01“…Findings from this study may provide governments and pharmaceutical companies with a strong reference for future research.…”
Get full text
Article -
2557
Complementary and Alternative Medicines in Northern Cyprus: Public Awareness, Patterns of Use, and Attitudes
Published 2023-03-01“…Given our finding that dissatisfaction with modern medicine is the most important reason for the preferred use of herbal medicines, government agencies, physicians, and pharmaceutical companies should be aware of this issue and should aim to create some level of awareness among users.…”
Get full text
Article -
2558
The Quality of Instructional YouTube Videos for the Administration of Intranasal Spray: Observational Study
Published 2020-12-01“…ResultsWe identified 33 YouTube videos made by different health care professionals and pharmaceutical companies around the world. None of the videos displayed all the steps correctly, while 5 of the 33 (15%) videos displayed over 75% of the steps correctly. …”
Get full text
Article -
2559
Intranasal Corticosteroids for the Medical Management of Nasal Polyps in Adults: a Meta-Analysis
Published 2007-11-01“…Search Strategy: Comprehensive search of Cochrane's Controlled Trials Registry (CCTR) Issue 2, 2003, Medline 1966 to 2002, and Embase 1974 - 2002 bibliographic review, requests for information from authors and pharmaceutical companies. Data collection and analysis: Sixteen studies were evaluated for inclusion, and trial quality, validity assessment, and completion of data extraction were done. …”
Get full text
Article -
2560
State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines
Published 2022-12-01“…Background State capture by the pharmaceutical industry is a form of corruption whereby pharmaceutical companies shift laws or policies about their products away from the best interest of the public and toward their private benefit. …”
Get full text
Article